Related Experiment Video

Updated: Mar 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Patients' perceptions about the implementation of Revised National Tuberculosis Control Programme of India

S K Verma1, Karthik Nagaraju1, Surya Kant1

  • 1Department of Pulmonary Medicine, King George's Medical University, Chowk, Lucknow, UP, India.

The Indian Journal of Tuberculosis
|July 26, 2016
PubMed

Insights

Most patients were satisfied with Directly Observed Treatment, Short-course (DOTS) services under India's Revised National Tuberculosis Control Programme (RNTCP), despite limited disease awareness. DOTS provider behavior was highly rated, facilitating treatment adherence.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Health Services Research

Background:

  • The Revised National Tuberculosis Control Programme (RNTCP) was implemented in India in 1993 to combat tuberculosis.
  • Patient perspectives are crucial for evaluating and improving TB control strategies.

Purpose of the Study:

  • To assess patient perceptions of the RNTCP implementation in North India.
  • To identify areas of satisfaction and challenges in patient experiences with DOTS.

Main Methods:

  • A cross-sectional study was conducted in a North Indian teaching hospital.
  • Data were collected via pre-designed questionnaires and personal interviews with patients between March and July 2014.

Main Results:

  • A significant majority of patients (91.5% and 93.5%) found DOTS provider behavior supportive and satisfactory.
  • Despite limited disease awareness (74.5%), most patients (90.5%) reported no difficulty accessing DOTS centers.
  • Overall treatment satisfaction was high, with 64% completely satisfied.

Conclusions:

  • Patient satisfaction with DOTS services under RNTCP is generally high, particularly regarding provider interactions.
  • Improving patient awareness about tuberculosis and their treatment is essential for enhancing program effectiveness.
  • The RNTCP demonstrates success in patient-centered care delivery, though further health education is recommended.
Abstract

Keywords:
SatisfactionTreatmentTuberculosisViews

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
737
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
617
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
316